Tuesday, 3 September 2019
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX: $DN.TO) (OTCQX: $VRNDF) (OTCQB: $GBLX) (TSX: $TGOD.TO) (OTC: $TGODF), (OTCQB: $SING)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX:
$DN.TO) (OTCQX: $VRNDF) (OTCQB: $GBLX)
(TSX: $TGOD.TO)
(OTC: $TGODF), (OTCQB: $SING)
Delta, Kelowna BC –September 3, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at
Today's podcast overview/transcript
Good afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
But first, The Assembly of First Nations
(AFN) is convening its first ever National Cannabis Summit on
September 4-5, 2019 in Vancouver British Columbia on the territory of the
Musqueam, Squamish and Tsleil-Waututh Nations.
Hundreds of delegates will gather to engage on the latest information
and research relating to First Nations and cannabis, including key issues in
areas like jurisdiction over sales and regulation, health impacts, social
development impacts and economic development.
The Summit is taking place at the Westin
Bayshore Hotel located at 1601 Bayshore Drive.
The federal government passed the Cannabis
Act and related legislation in 2018 and legal cannabis is now a reality.
However, there are many issues and questions involving First Nations and
cannabis that have not been properly addressed. The AFN's first ever National
Cannabis Summit will be one of the most comprehensive examinations of the
issues and the path forward to date. Delegates attending the Cannabis Summit
will have the opportunity to hear from a number of high-profile speakers on
many topics addressing the gaps in cannabis legislation, economic opportunities
and First Nations jurisdiction and governance.
The Summit will advance the dialogue around First Nations and cannabis,
inclusive of all approaches and perspectives on cannabis legalization.
DELTA 9 CANNABIS
INC. (TSX:DN.TO)
(OTCQX: VRNDF) announced that on August 30, 2019 it received its
renewal license from Health Canada for a term of three years. This license
authorizes Delta 9 to cultivate, process and sell cannabis from its Winnipeg
production facility. The Company also provided investors with an update on
cannabis oils sales, cannabis pre-rolls sales, and new product development.
The
Company, through its subsidiary, Delta 9 Bio-Tech Inc. has received its renewed
Standard Cultivation and Standard Processing license for cannabis from Health
Canada. The Company has fulfilled Health Canada's rigorous specifications, and
successfully passed all inspections.
"Delta
9 employees have worked hard to meet the requirements within Health Canada's
strictly regulated licensing environment. It speaks to the professionalism of
our team that it has maintained the high standards of safety, quality and
security in accordance with Health Canada's regulations for licensed producers,"
said John Arbuthnot, Chief Executive Officer of Delta 9.
The
Company has also received approval from Health Canada for sales of cannabis oil
products. The Company has already completed production of several initial
batches of its "Odyssey" and "Oasis" lines of ingestible
oils and will proceed with sales of these products in the medical and
recreational use cannabis markets.
In
June this year the Company launched its "Bliss" line of pre-rolled
cannabis products, which consist of blended cannabis flower, rolled in a
cigarette format, or "joint" for sale in the medical and recreational
use cannabis markets. To date the Company has produced and sold over 75,000
cannabis pre-rolls.
"It
is management's belief that these products will become an increasingly important
component of the medical and recreational use cannabis markets in the
future," said John Arbuthnot, Chief Executive Officer of Delta 9. "A
continually expanding line of high-quality cannabis products is a major goal
for the Company over this year and this is the first of what we hope are
several milestones in our progress."
Delta
9 has also acquired an exclusive license in Canada to manufacture and sell
products made with the patented technology of Nanosphere Health Sciences Inc.
for the delivery of cannabinoids via nanoparticle technology. The two companies
are in the process of developing the first product for Canada; an intraoral
cannabis oil containing cannabinoid nanoparticles.
The
NanoSphere delivery system for cannabis works by nano-encapsulating active
ingredients in phospholipid membranes for transportation through the skin and
mucosa into the bloodstream within minutes. Cannabis applications of the
technology include transdermal viscous gels, intranasal products and intraoral
products, all of which provide rapid results, precise dosages and high
bioavailability. The NanoSphere delivery system of cannabis can eliminate the
need for inhalation or ingestion of cannabis, offering users a potentially
safer and more effective method of consumption.
GB Sciences, Inc. (OTCQB: GBLX) today announced that it has received notification from the
U.S. Drug Enforcement Agency (DEA) that prior to making any decisions on the
pending applications, the DEA intends to distribute regulations that govern the
program of growing marijuana for scientific research under DEA registration. GB
Sciences is one of just 33 companies that applied to the DEA to become
registered under the Controlled Substances Act (CSA) to grow marijuana in order
to supply DEA-registered researchers in the United States. Last week, after a
three-year delay and following pressure by Congress, patients and researchers,
the DEA announced that it will move forward with creating revised regulations
and with reviewing the applications.
"We
are well-positioned to meet and exceed the DEA's criteria, and we intend to
aggressively pursue federal licensure," said Dr. Andrea Small-Howard,
Chief Science Officer and Director of GB Sciences. "The sophistication of
our facilities, our team's deep scientific experience, and our groundbreaking
cannabinoid therapies are unparalleled in the United States."
According
to the letter from the DEA, it is looking to facilitate research, advance
scientific understanding about the effects of marijuana, and potentially aid in
the development of safe and effective drug products that may be approved for
marketing by the Food and Drug Administration.
The Green Organic
Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF), announced that it has obtained approval from Health
Canada, under the Cannabis Regulations, to expand operations into its new
hybrid greenhouse located in Hamilton, Ontario. The 123,000 square foot
state-of-the-art facility will serve to increase TGOD's premium organic
cannabis production as it expands its sales in Canada.
TGOD's
hybrid greenhouse is the fruit of years of research and development. From its
cutting-edge climate control systems and water recapture systems to LED
lighting, it combines the latest technologies with natural elements such as
living soil and natural sunlight. This
organic growing facility has a much better environmental footprint and lower
waste than traditional large-scale cannabis growing.
"We
are thrilled to start using this purpose-built hybrid greenhouse as we ramp up
our production of premium organic cannabis, an underserved segment of the
market," commented Brian Athaide, CEO of TGOD. "Our team pioneered the concept of
growing organic cannabis at scale; this hybrid greenhouse has been artfully
designed for organic cultivation, allowing us to reliably produce clean, safe
and non irradiated cannabis."
The
new facility is the third phase of TGOD's Hamilton site, measuring 166,000
square feet with an annual production capacity of 17,500 kgs of premium organic
cannabis. In line with its commitment to
sustainability, TGOD aims to have the building LEED certified.
The
Company is also seeking an eGMP certification for this facility in order to
allow for global exports, as laws and regulations permit.
SinglePoint Inc. (OTCQB: SING) announced that its subsidiary Direct Solar of
America is planning along with GSX International Group and other larger
corporations a first of its kind Hemp distribution center. Direct Solar of
America will provide all energy solutions to production and distribution
centers along with energy solutions to independent farmers in the co-op.
Additionally, Direct Solar of America will facilitate the selling or assigning
of ITCs between the farmers and centers or other third parties.
The
opportunity to expand into the hemp market represents an opportunity to enter a
market that is projected to be a multi-billion dollar market in just a few
short years. An organization that can effectively combine the resources of
small hemp farmers and establish centralized processing and distribution
centers could corner the market on hemp processing for the foreseeable future.
Combined with the current tax incentives offered through ITCs and Opportunity
Zones, organizations that can access both will stand to reap the biggest
profits.
The
overall profit potential is enormous given the current solar tax incentives
along with opportunity zone exemptions. The project is projected to be fully
profitable within 3-4 growing cycles. Southern farmers will have multiple
growing cycles during the year, while northern farmers will be traditionally
limited to one per season. The real benefit of this structure is to take
advantage of the tax exemptions currently available for opportunity zone
development. It is this financial incentive that will make the project
profitable within 24-36 months.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available
on iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Friday, 30 August 2019
Investorideas.com - Cannabis Stock News: Westleaf Inc. (TSX-V:WL) (OTCQB:WSLFF) Announces Second Quarter 2019 Results and Update on Positioning for Cannabis 2.0
Investorideas.com - Cannabis Stock News: Westleaf Inc. (TSX-V:WL) (OTCQB:WSLFF) Announces Second Quarter 2019 Results and Update on Positioning for Cannabis 2.0
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - Cannabis Stock News: Dixie Brands (CSE: DIXI.U), (OTCQX: DXBRF) Announces Second Quarter 2019 Financial Results
Investorideas.com - Cannabis Stock News: Dixie Brands (CSE: DIXI.U), (OTCQX: DXBRF) Announces Second Quarter 2019 Financial Results
www.investorideas.com - news that inspires big ideas
www.investorideas.com - news that inspires big ideas
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...